chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash, SARS-CoV-2 test
Clinical narrative: itching; Each time I got a Covid vaccine (2 initial doses and 2 boosters), I got a 'torso' rash over my whole front and back after a few days; redness; The initial case was missing the following minimum criteria: Unspecified AE. Upon receipt of follow-up information on 22Aug2022, this case now contains all required information to be considered valid. This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old female patient received BNT162b2 (BNT162B2), on 14Apr2021 as dose 2, single (Lot number: ER8729) at the age of 62 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Seasonal allergies" (ongoing), notes: Onset date- since childhood, stop date- ongoing, no meds taken for many years.; "Osteoporosis", start date: 2012 (ongoing), notes: stop date- ongoing, Diagnosed in 2012 during screening test. No fractures no medication yet.; "Prior post fever rashes after some illness", start date: 1990 (ongoing), notes: Onset date- 1990's, stop date- ongoing, intermittent may be once every few years. Concomitant medication(s) included: CITRACAL [CALCIUM CITRATE] oral taken for osteoporosis (ongoing); VIT D [VITAMIN D NOS] oral taken for osteoporosis (ongoing). Past drug history included: Thimerosal, start date: 1980, reaction(s): "Thimerosal allergy", notes: Onset date- since early 1980's, stop date- ongoing, Diagnosed by eye doctor due to thimerosal in contact lens solution. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Time: 16:30 hrs., Anatomical site: Left Arm, Route of administration- Intramuscular, Batch/lot no: ER8732), administration date: 24Mar2021, when the patient was 62-year-old, for Covid-19 immunization, reaction(s): "itching", "Rash", "redness". The following information was reported: RASH (non-serious) with onset 17Apr2021, outcome "recovered", described as "Each time I got a Covid vaccine (2 initial doses and 2 boosters), I got a 'torso' rash over my whole front and back after a few days"; PRURITUS (non-serious) with onset 17Apr2021, outcome "recovered", described as "itching"; ERYTHEMA (non-serious) with onset 17Apr2021, outcome "recovered", described as "redness". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pruritus, rash, erythema. Additional information: Patient did not have any prior vaccination within 4 weeks. Family medical history relevant to AEs: No known family history for adverse events related to vaccines. Patient had no history of reaction to any other vaccine including flu and shingles. Specific Relevant tests for thromboembolic events with thrombocytopenia was reported as none. Facility type for vaccine was reported as Primary care clinic. This report was not related to a study or program.
Age: 15.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Allergy test negative, Asthenia, Blood glucose normal, Colonoscopy normal, Diarrhoea
Clinical narrative: swollen arm , tender to touch and move, nausea vomiting, diarrhea, dizzy, weakness,  lost 55 lbs, since second vaccine symptoms began and still ongoing
Age: 15.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Full blood count normal, Laboratory test normal, Loss of personal independence in daily activities, Malaise
Clinical narrative: swollen arm , tender to touch and move, nausea vomiting, diarrhea, dizzy, weakness,  lost 55 lbs, since second vaccine symptoms began and still ongoing
Age: 15.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Metabolic function test normal, Nausea, Pain, Peripheral swelling, Swallow study
Clinical narrative: swollen arm , tender to touch and move, nausea vomiting, diarrhea, dizzy, weakness,  lost 55 lbs, since second vaccine symptoms began and still ongoing
Age: 15.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tenderness, Ultrasound biliary tract, Vomiting, Weight decreased, X-ray with contrast lower gastrointestinal tract
Clinical narrative: swollen arm , tender to touch and move, nausea vomiting, diarrhea, dizzy, weakness,  lost 55 lbs, since second vaccine symptoms began and still ongoing
Age: 15.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: X-ray with contrast upper gastrointestinal tract
Clinical narrative: swollen arm , tender to touch and move, nausea vomiting, diarrhea, dizzy, weakness,  lost 55 lbs, since second vaccine symptoms began and still ongoing
Age: 30.0
Sex: M
Vaccine: UNK
Symptoms: Muscle tightness, Syncope, Tremor
Clinical narrative: Patient fainted after receiving the vaccine. He stated that this happens when he receives vaccines. He had not eaten this morning. He experienced very mild (less than 5 seconds in duration) shaking and clinching of left hand.
Age: 15.0
Sex: F
Vaccine: SMALLMNK
Symptoms: Incorrect route of product administration
Clinical narrative: Jynneos Vaccine was administered  0.1 ml Intradermal instead of 0.5 ml subcutaneous since she is a minor below 18 years old. Administered on the left arm, created a wheal, patient did not present any respiratory complaints or weakness, Mother was present, provided information and health education regarding the vaccination given. Mother is a nurse  and verbalized understanding. Patient left with mother alert, ambulatory, in good spirit.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Extra dose administered
Clinical narrative: Nurse gave patient a third dose of MMRV when the patient was only due for her kinrix.  This was her third dose of MMR and Varicella
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Vitiligo
Clinical narrative: I have developed vitiligo, I have patches on both the left and right wrist. No known family history.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Cardiomyopathy, Chest pain, Dyspnoea, Echocardiogram abnormal
Clinical narrative: Shortness of breath, jaw, chest and left shoulder pain. emesis
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Ejection fraction, Pain in jaw, Vomiting
Clinical narrative: Shortness of breath, jaw, chest and left shoulder pain. emesis
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Acquired diaphragmatic eventration, Acute kidney injury, Alanine aminotransferase increased, Albumin globulin ratio decreased, Anion gap
Clinical narrative: 49 y.o.   Admit Date:  7/2/2022   Discharge Date: 7/6/22   Principal Dx/ Final Dx: Chronic obstructive pulmonary disease with acute exacerbation   Relevant Inpt Dx: Principal Problem:   Chronic obstructive pulmonary disease with acute exacerbation Active Problems:   History of peripheral stem cell transplant   COVID-19 virus infection   Chronic systolic congestive heart failure   Tobacco abuse       HPI:   Hospital Course:   This 49 year old man with copd and cardiomyopathy was admitted with sob.  He had copd exacerbation and covid and chf.   He was treated for copd with nebs and inhalers and steroids.  He did get empiric antibiotics.  He is improved and will taper steroids.  He was treated for covid with remdesivir and is doing well.  Course is complete   He had chf with  acute on chronic systolic chf.  He was given iv lasix.  He did improve but had aki from overdiuresis.  He is now on oral lasix and aldactone has been held.  He will go home wearing life vest and will follow up with cardiology after quarantine ends.             Consults:   IP CONSULT TO SEPSIS NURSE NAVIGATOR IP CONSULT TO CARDIOLOGY       Disposition:  home   Discharge Condition:  fair
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Arteriogram carotid abnormal, Aspartate aminotransferase increased, Base excess, Blood albumin normal, Blood alkaline phosphatase increased
Clinical narrative: 49 y.o.   Admit Date:  7/2/2022   Discharge Date: 7/6/22   Principal Dx/ Final Dx: Chronic obstructive pulmonary disease with acute exacerbation   Relevant Inpt Dx: Principal Problem:   Chronic obstructive pulmonary disease with acute exacerbation Active Problems:   History of peripheral stem cell transplant   COVID-19 virus infection   Chronic systolic congestive heart failure   Tobacco abuse       HPI:   Hospital Course:   This 49 year old man with copd and cardiomyopathy was admitted with sob.  He had copd exacerbation and covid and chf.   He was treated for copd with nebs and inhalers and steroids.  He did get empiric antibiotics.  He is improved and will taper steroids.  He was treated for covid with remdesivir and is doing well.  Course is complete   He had chf with  acute on chronic systolic chf.  He was given iv lasix.  He did improve but had aki from overdiuresis.  He is now on oral lasix and aldactone has been held.  He will go home wearing life vest and will follow up with cardiology after quarantine ends.             Consults:   IP CONSULT TO SEPSIS NURSE NAVIGATOR IP CONSULT TO CARDIOLOGY       Disposition:  home   Discharge Condition:  fair
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Blood bicarbonate increased, Blood bilirubin normal, Blood calcium normal, Blood chloride decreased, Blood creatinine normal
Clinical narrative: 49 y.o.   Admit Date:  7/2/2022   Discharge Date: 7/6/22   Principal Dx/ Final Dx: Chronic obstructive pulmonary disease with acute exacerbation   Relevant Inpt Dx: Principal Problem:   Chronic obstructive pulmonary disease with acute exacerbation Active Problems:   History of peripheral stem cell transplant   COVID-19 virus infection   Chronic systolic congestive heart failure   Tobacco abuse       HPI:   Hospital Course:   This 49 year old man with copd and cardiomyopathy was admitted with sob.  He had copd exacerbation and covid and chf.   He was treated for copd with nebs and inhalers and steroids.  He did get empiric antibiotics.  He is improved and will taper steroids.  He was treated for covid with remdesivir and is doing well.  Course is complete   He had chf with  acute on chronic systolic chf.  He was given iv lasix.  He did improve but had aki from overdiuresis.  He is now on oral lasix and aldactone has been held.  He will go home wearing life vest and will follow up with cardiology after quarantine ends.             Consults:   IP CONSULT TO SEPSIS NURSE NAVIGATOR IP CONSULT TO CARDIOLOGY       Disposition:  home   Discharge Condition:  fair
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Blood gases, Blood glucose normal, Blood lactic acid normal, Blood osmolarity decreased, Blood pH normal
Clinical narrative: 49 y.o.   Admit Date:  7/2/2022   Discharge Date: 7/6/22   Principal Dx/ Final Dx: Chronic obstructive pulmonary disease with acute exacerbation   Relevant Inpt Dx: Principal Problem:   Chronic obstructive pulmonary disease with acute exacerbation Active Problems:   History of peripheral stem cell transplant   COVID-19 virus infection   Chronic systolic congestive heart failure   Tobacco abuse       HPI:   Hospital Course:   This 49 year old man with copd and cardiomyopathy was admitted with sob.  He had copd exacerbation and covid and chf.   He was treated for copd with nebs and inhalers and steroids.  He did get empiric antibiotics.  He is improved and will taper steroids.  He was treated for covid with remdesivir and is doing well.  Course is complete   He had chf with  acute on chronic systolic chf.  He was given iv lasix.  He did improve but had aki from overdiuresis.  He is now on oral lasix and aldactone has been held.  He will go home wearing life vest and will follow up with cardiology after quarantine ends.             Consults:   IP CONSULT TO SEPSIS NURSE NAVIGATOR IP CONSULT TO CARDIOLOGY       Disposition:  home   Discharge Condition:  fair
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Blood potassium normal, Blood sodium normal, Blood urea increased, Brain natriuretic peptide increased, COVID-19
Clinical narrative: 49 y.o.   Admit Date:  7/2/2022   Discharge Date: 7/6/22   Principal Dx/ Final Dx: Chronic obstructive pulmonary disease with acute exacerbation   Relevant Inpt Dx: Principal Problem:   Chronic obstructive pulmonary disease with acute exacerbation Active Problems:   History of peripheral stem cell transplant   COVID-19 virus infection   Chronic systolic congestive heart failure   Tobacco abuse       HPI:   Hospital Course:   This 49 year old man with copd and cardiomyopathy was admitted with sob.  He had copd exacerbation and covid and chf.   He was treated for copd with nebs and inhalers and steroids.  He did get empiric antibiotics.  He is improved and will taper steroids.  He was treated for covid with remdesivir and is doing well.  Course is complete   He had chf with  acute on chronic systolic chf.  He was given iv lasix.  He did improve but had aki from overdiuresis.  He is now on oral lasix and aldactone has been held.  He will go home wearing life vest and will follow up with cardiology after quarantine ends.             Consults:   IP CONSULT TO SEPSIS NURSE NAVIGATOR IP CONSULT TO CARDIOLOGY       Disposition:  home   Discharge Condition:  fair
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Carbon dioxide increased, Cardiac assistance device user, Cardiac failure acute, Cardiac failure congestive, Chest X-ray abnormal
Clinical narrative: 49 y.o.   Admit Date:  7/2/2022   Discharge Date: 7/6/22   Principal Dx/ Final Dx: Chronic obstructive pulmonary disease with acute exacerbation   Relevant Inpt Dx: Principal Problem:   Chronic obstructive pulmonary disease with acute exacerbation Active Problems:   History of peripheral stem cell transplant   COVID-19 virus infection   Chronic systolic congestive heart failure   Tobacco abuse       HPI:   Hospital Course:   This 49 year old man with copd and cardiomyopathy was admitted with sob.  He had copd exacerbation and covid and chf.   He was treated for copd with nebs and inhalers and steroids.  He did get empiric antibiotics.  He is improved and will taper steroids.  He was treated for covid with remdesivir and is doing well.  Course is complete   He had chf with  acute on chronic systolic chf.  He was given iv lasix.  He did improve but had aki from overdiuresis.  He is now on oral lasix and aldactone has been held.  He will go home wearing life vest and will follow up with cardiology after quarantine ends.             Consults:   IP CONSULT TO SEPSIS NURSE NAVIGATOR IP CONSULT TO CARDIOLOGY       Disposition:  home   Discharge Condition:  fair
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Chronic obstructive pulmonary disease, Condition aggravated, Differential white blood cell count, Diuretic therapy
Clinical narrative: 49 y.o.   Admit Date:  7/2/2022   Discharge Date: 7/6/22   Principal Dx/ Final Dx: Chronic obstructive pulmonary disease with acute exacerbation   Relevant Inpt Dx: Principal Problem:   Chronic obstructive pulmonary disease with acute exacerbation Active Problems:   History of peripheral stem cell transplant   COVID-19 virus infection   Chronic systolic congestive heart failure   Tobacco abuse       HPI:   Hospital Course:   This 49 year old man with copd and cardiomyopathy was admitted with sob.  He had copd exacerbation and covid and chf.   He was treated for copd with nebs and inhalers and steroids.  He did get empiric antibiotics.  He is improved and will taper steroids.  He was treated for covid with remdesivir and is doing well.  Course is complete   He had chf with  acute on chronic systolic chf.  He was given iv lasix.  He did improve but had aki from overdiuresis.  He is now on oral lasix and aldactone has been held.  He will go home wearing life vest and will follow up with cardiology after quarantine ends.             Consults:   IP CONSULT TO SEPSIS NURSE NAVIGATOR IP CONSULT TO CARDIOLOGY       Disposition:  home   Discharge Condition:  fair
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram PR shortened, Electrocardiogram QT interval, Electrocardiogram QT prolonged, Electrocardiogram ST segment depression
Clinical narrative: 49 y.o.   Admit Date:  7/2/2022   Discharge Date: 7/6/22   Principal Dx/ Final Dx: Chronic obstructive pulmonary disease with acute exacerbation   Relevant Inpt Dx: Principal Problem:   Chronic obstructive pulmonary disease with acute exacerbation Active Problems:   History of peripheral stem cell transplant   COVID-19 virus infection   Chronic systolic congestive heart failure   Tobacco abuse       HPI:   Hospital Course:   This 49 year old man with copd and cardiomyopathy was admitted with sob.  He had copd exacerbation and covid and chf.   He was treated for copd with nebs and inhalers and steroids.  He did get empiric antibiotics.  He is improved and will taper steroids.  He was treated for covid with remdesivir and is doing well.  Course is complete   He had chf with  acute on chronic systolic chf.  He was given iv lasix.  He did improve but had aki from overdiuresis.  He is now on oral lasix and aldactone has been held.  He will go home wearing life vest and will follow up with cardiology after quarantine ends.             Consults:   IP CONSULT TO SEPSIS NURSE NAVIGATOR IP CONSULT TO CARDIOLOGY       Disposition:  home   Discharge Condition:  fair
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram T wave abnormal, Electrocardiogram abnormal, Full blood count, Glomerular filtration rate normal, Haematocrit decreased
Clinical narrative: 49 y.o.   Admit Date:  7/2/2022   Discharge Date: 7/6/22   Principal Dx/ Final Dx: Chronic obstructive pulmonary disease with acute exacerbation   Relevant Inpt Dx: Principal Problem:   Chronic obstructive pulmonary disease with acute exacerbation Active Problems:   History of peripheral stem cell transplant   COVID-19 virus infection   Chronic systolic congestive heart failure   Tobacco abuse       HPI:   Hospital Course:   This 49 year old man with copd and cardiomyopathy was admitted with sob.  He had copd exacerbation and covid and chf.   He was treated for copd with nebs and inhalers and steroids.  He did get empiric antibiotics.  He is improved and will taper steroids.  He was treated for covid with remdesivir and is doing well.  Course is complete   He had chf with  acute on chronic systolic chf.  He was given iv lasix.  He did improve but had aki from overdiuresis.  He is now on oral lasix and aldactone has been held.  He will go home wearing life vest and will follow up with cardiology after quarantine ends.             Consults:   IP CONSULT TO SEPSIS NURSE NAVIGATOR IP CONSULT TO CARDIOLOGY       Disposition:  home   Discharge Condition:  fair
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Left ventricular failure, Lung disorder, Mean cell haemoglobin concentration normal, Mean cell haemoglobin increased
Clinical narrative: 49 y.o.   Admit Date:  7/2/2022   Discharge Date: 7/6/22   Principal Dx/ Final Dx: Chronic obstructive pulmonary disease with acute exacerbation   Relevant Inpt Dx: Principal Problem:   Chronic obstructive pulmonary disease with acute exacerbation Active Problems:   History of peripheral stem cell transplant   COVID-19 virus infection   Chronic systolic congestive heart failure   Tobacco abuse       HPI:   Hospital Course:   This 49 year old man with copd and cardiomyopathy was admitted with sob.  He had copd exacerbation and covid and chf.   He was treated for copd with nebs and inhalers and steroids.  He did get empiric antibiotics.  He is improved and will taper steroids.  He was treated for covid with remdesivir and is doing well.  Course is complete   He had chf with  acute on chronic systolic chf.  He was given iv lasix.  He did improve but had aki from overdiuresis.  He is now on oral lasix and aldactone has been held.  He will go home wearing life vest and will follow up with cardiology after quarantine ends.             Consults:   IP CONSULT TO SEPSIS NURSE NAVIGATOR IP CONSULT TO CARDIOLOGY       Disposition:  home   Discharge Condition:  fair
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Mean cell volume increased, Mean platelet volume normal, Metabolic function test, Musculoskeletal chest pain, PCO2 increased
Clinical narrative: 49 y.o.   Admit Date:  7/2/2022   Discharge Date: 7/6/22   Principal Dx/ Final Dx: Chronic obstructive pulmonary disease with acute exacerbation   Relevant Inpt Dx: Principal Problem:   Chronic obstructive pulmonary disease with acute exacerbation Active Problems:   History of peripheral stem cell transplant   COVID-19 virus infection   Chronic systolic congestive heart failure   Tobacco abuse       HPI:   Hospital Course:   This 49 year old man with copd and cardiomyopathy was admitted with sob.  He had copd exacerbation and covid and chf.   He was treated for copd with nebs and inhalers and steroids.  He did get empiric antibiotics.  He is improved and will taper steroids.  He was treated for covid with remdesivir and is doing well.  Course is complete   He had chf with  acute on chronic systolic chf.  He was given iv lasix.  He did improve but had aki from overdiuresis.  He is now on oral lasix and aldactone has been held.  He will go home wearing life vest and will follow up with cardiology after quarantine ends.             Consults:   IP CONSULT TO SEPSIS NURSE NAVIGATOR IP CONSULT TO CARDIOLOGY       Disposition:  home   Discharge Condition:  fair
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: PO2 normal, Platelet count normal, Procalcitonin, Protein total normal, Pulmonary fibrosis
Clinical narrative: 49 y.o.   Admit Date:  7/2/2022   Discharge Date: 7/6/22   Principal Dx/ Final Dx: Chronic obstructive pulmonary disease with acute exacerbation   Relevant Inpt Dx: Principal Problem:   Chronic obstructive pulmonary disease with acute exacerbation Active Problems:   History of peripheral stem cell transplant   COVID-19 virus infection   Chronic systolic congestive heart failure   Tobacco abuse       HPI:   Hospital Course:   This 49 year old man with copd and cardiomyopathy was admitted with sob.  He had copd exacerbation and covid and chf.   He was treated for copd with nebs and inhalers and steroids.  He did get empiric antibiotics.  He is improved and will taper steroids.  He was treated for covid with remdesivir and is doing well.  Course is complete   He had chf with  acute on chronic systolic chf.  He was given iv lasix.  He did improve but had aki from overdiuresis.  He is now on oral lasix and aldactone has been held.  He will go home wearing life vest and will follow up with cardiology after quarantine ends.             Consults:   IP CONSULT TO SEPSIS NURSE NAVIGATOR IP CONSULT TO CARDIOLOGY       Disposition:  home   Discharge Condition:  fair
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: QRS axis, Red blood cell count decreased, Red cell distribution width increased, Right atrial enlargement, Scan with contrast abnormal
Clinical narrative: 49 y.o.   Admit Date:  7/2/2022   Discharge Date: 7/6/22   Principal Dx/ Final Dx: Chronic obstructive pulmonary disease with acute exacerbation   Relevant Inpt Dx: Principal Problem:   Chronic obstructive pulmonary disease with acute exacerbation Active Problems:   History of peripheral stem cell transplant   COVID-19 virus infection   Chronic systolic congestive heart failure   Tobacco abuse       HPI:   Hospital Course:   This 49 year old man with copd and cardiomyopathy was admitted with sob.  He had copd exacerbation and covid and chf.   He was treated for copd with nebs and inhalers and steroids.  He did get empiric antibiotics.  He is improved and will taper steroids.  He was treated for covid with remdesivir and is doing well.  Course is complete   He had chf with  acute on chronic systolic chf.  He was given iv lasix.  He did improve but had aki from overdiuresis.  He is now on oral lasix and aldactone has been held.  He will go home wearing life vest and will follow up with cardiology after quarantine ends.             Consults:   IP CONSULT TO SEPSIS NURSE NAVIGATOR IP CONSULT TO CARDIOLOGY       Disposition:  home   Discharge Condition:  fair
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Sinus tachycardia, Troponin I increased, White blood cell count increased
Clinical narrative: 49 y.o.   Admit Date:  7/2/2022   Discharge Date: 7/6/22   Principal Dx/ Final Dx: Chronic obstructive pulmonary disease with acute exacerbation   Relevant Inpt Dx: Principal Problem:   Chronic obstructive pulmonary disease with acute exacerbation Active Problems:   History of peripheral stem cell transplant   COVID-19 virus infection   Chronic systolic congestive heart failure   Tobacco abuse       HPI:   Hospital Course:   This 49 year old man with copd and cardiomyopathy was admitted with sob.  He had copd exacerbation and covid and chf.   He was treated for copd with nebs and inhalers and steroids.  He did get empiric antibiotics.  He is improved and will taper steroids.  He was treated for covid with remdesivir and is doing well.  Course is complete   He had chf with  acute on chronic systolic chf.  He was given iv lasix.  He did improve but had aki from overdiuresis.  He is now on oral lasix and aldactone has been held.  He will go home wearing life vest and will follow up with cardiology after quarantine ends.             Consults:   IP CONSULT TO SEPSIS NURSE NAVIGATOR IP CONSULT TO CARDIOLOGY       Disposition:  home   Discharge Condition:  fair
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Amnesia, Antinuclear antibody positive, Arthralgia, Fatigue
Clinical narrative: I am a 61 year old female, who had been in good health prior to taking the Covid Vaccines, I have no history of ANY auto immune disease in my medical history or in my family history.    After taking my last Covid Booster in Nov. of 2021, I began to experience EXTREME fatigue, hair loss, loss of memory and TERRIBLE pain and swelling in my fingers and legs.    I saw my Primary doctor in May 2022, when my symptoms were VERY severe.  My PCP, suggested that I be tested for Lupus, and I asked to be tested for RA since I had so much joint pain and swelling.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Immunology test, Joint swelling, Laboratory test, Pain in extremity, Peripheral swelling
Clinical narrative: I am a 61 year old female, who had been in good health prior to taking the Covid Vaccines, I have no history of ANY auto immune disease in my medical history or in my family history.    After taking my last Covid Booster in Nov. of 2021, I began to experience EXTREME fatigue, hair loss, loss of memory and TERRIBLE pain and swelling in my fingers and legs.    I saw my Primary doctor in May 2022, when my symptoms were VERY severe.  My PCP, suggested that I be tested for Lupus, and I asked to be tested for RA since I had so much joint pain and swelling.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Gaze palsy, Seizure, Syncope
Clinical narrative: Patient's parent called today at 12:30pm, explaining that he had just witnessed the patient have either a fainting or seizure spell. Patient had been drinking carbonated soda, complained of chest pain, and had an episode where their eyes rolled to the back of their head and either fainted or seized. Parent is unsure. Patient is currently alert and oriented, talking, no lasting effects, no lasting verbal, sight, or motor issues. Suspected delayed syncope. Have not reported to hospital, and patient does not currently have an active primary care doctor. Expressed that if anything else happens to reach out to EMS or go to hospital for follow-up. Patient should be watched in-house for further issues if they decide to continue with second dose.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: gave a second 0.2 ml to get pt to 30 mcg of vaccine
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Vaccine was given in left arm 5 days ago. Left arm at injection site is red, swollen, sore, hot to touch, and itchy.  I have been taking Aleve once or twice a day for the pain. I just had a conference with a doctor  and he recommended I report this adverse reaction using this website. He categorized my symptoms as moderate because of the length of time of the reaction. He also recommended I put ice on it, rest it, and elevate it and continue taking Aleve as needed.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperventilation, Sleep apnoea syndrome
Clinical narrative: She seems to be breathing a little bit heavily in her sleep; She seems to be breathing a little bit heavily in her sleep; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  An 83-year-old female patient received BNT162b2 (BNT162B2), on 17Aug2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 83 years for covid-19 immunisation; clopidogrel bisulfate (PLAVIX), (Batch/Lot number: unknown) for intracranial aneurysm. The patient's relevant medical history included: "Cerebral Aneurysm" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization completed. (Dose 1 & 2), Covid-19 vaccine manufacturer unknown.), for COVID-19 immunization. The following information was reported: HYPERVENTILATION (non-serious), SLEEP APNOEA SYNDROME (non-serious) all with onset 17Aug2022, outcome "unknown" and all described as "She seems to be breathing a little bit heavily in her sleep".  Additional information: Reporter stated, "my mother is 83 and she takes Plavix for a Cerebral Aneurysm on a very tiny vein and we got one of the Covid boosters today and I am not even sure which one it was, was it the (Pharmacy name)? And I was wondering if there is any risk of that because she seems to be breathing a little bit heavily in her sleep. I was wondering if I should be concerned?"   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Joint swelling
Clinical narrative: swelling and redness at or near the elbow after receiving the Pfizer-BioNTech Covid 19 Vaccine (gray cap); swelling and redness at or near the elbow after receiving the Pfizer-BioNTech Covid 19 Vaccine (gray cap); This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: JOINT SWELLING (non-serious), ERYTHEMA (non-serious), outcome "unknown" and all described as "swelling and redness at or near the elbow after receiving the Pfizer-BioNTech Covid 19 Vaccine (gray cap)".  Additional Information: Anatomical Site of Vaccination was reported as deltoid muscle. Patient had swelling and redness near her elbow after receiving the Pfizer-BioNTech Covid 19 Vaccine (gray cap). She wanted to know the incidence of the Adverse Events for patients who are 60 years and older. Patient had swelling and redness at the elbow. Reporter just knew the NDC, it was the grey cap one, the middle of the NDC was 1025.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A female patient received BNT162b2 (BNT162B2), as dose 1, single (Lot number: EW0186) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious), outcome "recovered", described as "brain fog". Additional information: Both her vaccines were the same LOT numbers. Had severe brain fogs after the vaccines. With the first vaccine, the brain fog went away after the first night. But it came back after the second vaccine and she is now having cognitive problems. After the second vaccine, she didn't feel good for a couple of days. On the fifth day, she stood up and completely fell over. Ever since then she been recovering. She fell over on 12Sep2021. Received the second dose on 07Sep2021. Due to AE patient experienced after receiving vaccine, it was suggested to her that she could've gotten a bad batch or something. Her biggest concern is just the LOT. She was really terrified that she may have had something different than everyone else.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Skin discolouration
Clinical narrative: This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 26-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 09Aug2022 at 10:30 as dose 2, single (Lot number: Fp7139) at the age of 26 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Lot number: Fp7139; Anatomical location: Left arm, Administration Time: 10:30 AM), administration date: 19Jul2022, when the patient was 26-year-old, for COVID-19 Immunisation. The following information was reported: RASH (non-serious) with onset 09Aug2022 at 11:30, outcome "not recovered", described as "Both hands became having a rash an hour after the shot"; SKIN DISCOLOURATION (non-serious) with onset 09Aug2022 at 11:30, outcome "not recovered", described as "Both hands have purple spots". Therapeutic measures were not taken as a result of rash, skin discoloration. Additional information: It was reported that there was no other vaccine taken in four weeks. No treatment was taken. There was no COVID tested prior to vaccination. It was also reported that no known allergies and had no medical history. No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, SARS-CoV-2 test
Clinical narrative: This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 52-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Mar2021 as dose 2, single (Batch/Lot number: unknown) at the age of 51 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. The patient took concomitant medications. Vaccination history included: Bnt162b2 (dose number: 1, All 3 injections were administered in the right arm at each visit), administration date: Mar2021, when the patient was 51 years old, for COVID-19 Immunization, reaction(s): "About 1 week after dose #1 I experienced pain in the right shoulder joint and surrounding muscle"; Bnt162b2 (Prev dose dose number: 1, All 3 injections were administered in the right arm at each visit), administration date: Mar2021, when the patient was 51 years old, for COVID-19 Immunization, reaction(s): "About 1 week after dose #1 I experienced pain in the right shoulder joint and surrounding muscle". The following information was reported: MYALGIA (non-serious), ARTHRALGIA (non-serious) all with onset Mar2021, outcome "not recovered" and all described as "A few days after dose #2 I experienced increased pain in the right shoulder joint and surrounding muscle". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of myalgia, arthralgia. Additional information: All 3 injections were administered in the right arm at each visit. About 1 week after dose #1 I experienced pain in the right shoulder joint and surrounding muscle. A few days after dose #2 I experienced increased pain in the right shoulder joint and surrounding muscle. The symptoms reduced slightly but after dose #3 I again experienced increased pain in the right shoulder joint and surrounding muscle. These symptoms still continue. There is also pain when raising the arm overhead, lifting items overhead and performing any activity requiring rotation of the right shoulder. The left (did not have any injections) remains without any similar symptoms. AE treatment: applied heating pad & used analgesics. The patient was not priorly vaccinated for covid. The patient was not covid tested post vaccination. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Polymerase chain reaction
Clinical narrative: This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 52-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 51 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. The patient took concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; Lot Number: Unknown; Anatomical location: Arm right), administration date: Mar2021, when the patient was 51 years old, for Covid-19 immunization, reaction(s): "Pain in the right shoulder joint and surrounding muscle.", "Pain in the right shoulder joint and surrounding muscle."; Bnt162b2 (DOSE 2, SINGLE; Lot Number: Unknown; Anatomical location: Arm right), administration date: Mar2021, when the patient was 51 years old, for Covid-19 immunization, reaction(s): "Increased pain in the right shoulder joint and surrounding muscle.", "Increased pain in the right shoulder joint and surrounding muscle.". The following information was reported: ARTHRALGIA (non-serious), outcome "not recovered", described as "increased pain in the right shoulder joint and surrounding muscle/ there is also pain when raising the arm overhead, lifting items overhead and performing any activity requiring rotation of the right shoulder"; MYALGIA (non-serious), outcome "not recovered", described as "After dose #3 I again experienced increased pain in the right shoulder joint and surrounding muscle". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of arthralgia, myalgia. Additional information: There was also pain when raising the arm overhead, lifting items overhead and performing any activity requiring rotation of the right shoulder. The left (did not have any injections) remains without any similar symptoms. The patient received multivitamins. The patient did not have any medical history. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. The patient was treated with heating pad and used analgesics. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 83-year-old male patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "High BP" (unspecified if ongoing), notes: High BP; "High Cholesterol" (unspecified if ongoing). There were no concomitant medications.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional information: COVID 19 Treatment Paxlovid from 05Aug2022 to 11Aug2022,  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Cognitive disorder, Fall, Feeling abnormal, Malaise
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A female patient received BNT162b2 (BNT162B2), on 07Sep2021 as dose 2, single (Lot number: EW0186) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Covid-19 Vaccine:, Dose 1: Date: Unknown, LOT: EW0186), for Covid-19 Immunization, reaction(s): "Brain fog". The following information was reported: FALL (non-serious) with onset 12Sep2021, outcome "unknown", described as "fell over"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "brain fog"; BALANCE DISORDER (non-serious), outcome "unknown", described as "completely lost her balance/ lost her entire balance system"; VESTIBULAR DISORDER (non-serious), outcome "unknown", described as "having vestibular issues"; COGNITIVE DISORDER (non-serious), outcome "unknown", described as "cognitive problems"; MALAISE (non-serious), outcome "unknown", described as "didn't feel good". Clinical course: Additional Context: Has a question about the Covid-19 vaccine. Took the vaccine a year ago and after the second dose, she sat up one day and fell over. She completely lost her balance. Still recovering. It was suggested to her that she could've gotten a bad batch or something. Has anything been reported or is just the way she is responding to the vaccine. She lost her entire balance system. She cant drive, ride a bike, had to re learn a lot of things, having vestibular issues, cant do her career. Had to relearn how to ride her bike. Her biggest concern is just the LOT. Wants to get better. She was really terrified that she may have had something different than everyone else. Has anything like that been reported? Both her vaccines were the same LOT numbers. Had severe brain fogs after the vaccines. With the first vaccine, the brain fog went away after the first night. But it came back after the second vaccine and she is now having cognitive problems. After the second vaccine, she didn't feel good for a couple of days. On the fifth day, she stood up and completely fell over. Ever since then she's been recovering. She fell over on 12Sep2021. Received the second dose on 07Sep2021. Had no underlying conditions or anything or known problems. Was in a healthy state. That is all she really has to say or add about it.   Description of Product Complaint: Description of complaint: Due to AE patient experienced after receiving vaccine, it was suggested to her that she could've gotten a bad batch or something. Her biggest concern is just the LOT. She is really terrified that she may have had something different than everyone else.
Sex: F
Vaccine: COVID19
Symptoms: Vestibular disorder
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A female patient received BNT162b2 (BNT162B2), on 07Sep2021 as dose 2, single (Lot number: EW0186) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Covid-19 Vaccine:, Dose 1: Date: Unknown, LOT: EW0186), for Covid-19 Immunization, reaction(s): "Brain fog". The following information was reported: FALL (non-serious) with onset 12Sep2021, outcome "unknown", described as "fell over"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "brain fog"; BALANCE DISORDER (non-serious), outcome "unknown", described as "completely lost her balance/ lost her entire balance system"; VESTIBULAR DISORDER (non-serious), outcome "unknown", described as "having vestibular issues"; COGNITIVE DISORDER (non-serious), outcome "unknown", described as "cognitive problems"; MALAISE (non-serious), outcome "unknown", described as "didn't feel good". Clinical course: Additional Context: Has a question about the Covid-19 vaccine. Took the vaccine a year ago and after the second dose, she sat up one day and fell over. She completely lost her balance. Still recovering. It was suggested to her that she could've gotten a bad batch or something. Has anything been reported or is just the way she is responding to the vaccine. She lost her entire balance system. She cant drive, ride a bike, had to re learn a lot of things, having vestibular issues, cant do her career. Had to relearn how to ride her bike. Her biggest concern is just the LOT. Wants to get better. She was really terrified that she may have had something different than everyone else. Has anything like that been reported? Both her vaccines were the same LOT numbers. Had severe brain fogs after the vaccines. With the first vaccine, the brain fog went away after the first night. But it came back after the second vaccine and she is now having cognitive problems. After the second vaccine, she didn't feel good for a couple of days. On the fifth day, she stood up and completely fell over. Ever since then she's been recovering. She fell over on 12Sep2021. Received the second dose on 07Sep2021. Had no underlying conditions or anything or known problems. Was in a healthy state. That is all she really has to say or add about it.   Description of Product Complaint: Description of complaint: Due to AE patient experienced after receiving vaccine, it was suggested to her that she could've gotten a bad batch or something. Her biggest concern is just the LOT. She is really terrified that she may have had something different than everyone else.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: COVID 19; COVID 19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Mastocytosis" (unspecified if ongoing). Concomitant medication(s) included: NEXIUM [ESOMEPRAZOLE MAGNESIUM]; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; SINGULAIR. Past drug history included: Levaquin, reaction(s): "Known allergies: Levaquin"; Bactrum, reaction(s): "Known allergies: Bactrum". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Aug2022) Positive, notes: I started taking Paxlovid on Day 3 of symptoms; (15Aug2022) Negative, notes: I tested negative on Day 10; (16Aug2022) Positive, notes: On Day 11 I tested positive; (17Aug2022) Positive, notes: Today is Day 12 and I am still testing positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: It was reported that COVID 19 Treatment started at 08Aug2022 and stopped at 12Aug2022.I have a cough and congestion again.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 14Dec2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 41 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Obesity" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: indication=Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.